Bunkerhill Health Named Winner in Newsweek's AI Impact Awards 2026 for Second Consecutive Year
SAN FRANCISCO — May 19, 2026 — Bunkerhill Health, the platform partner behind the modern health system, today announced that it has been named the winner of the 2026 Newsweek AI Impact Awards in the category of “AI in Healthcare: Best Outcomes, Health Equity”. This marks the second consecutive year Bunkerhill has been recognized in the Newsweek AI Impact Awards.
The Newsweek AI Impact Awards celebrate organizations that are setting a new standard for the practical and responsible application of AI. Winners are recognized not for the promise of what their technology might do someday, but for the outcomes their work has actually produced.
In the scope of work this award recognizes, leaders at partner institutions are using Carebricks, Bunkerhill's agentic AI platform, to identify patients and care gaps that would otherwise be missed, prioritize based on real clinical need rather than administrative order, and ensure follow-through reliably and at scale. The result is fewer patients waiting unnecessarily, more patients reached, and care delivered when it is needed.
"This recognition belongs to the health systems doing this work," said Nishith Khandwala, CEO and co-founder of Bunkerhill Health. "Health equity challenges live at the intersection of clinical complexity and operational constraint, and the institutions building on Carebricks are showing what becomes possible when both can be addressed on the same platform. Our role is to enable what their leaders set out to build. Seeing that work recognized by Newsweek, for the second year in a row, means a great deal."
Health equity is one of many dimensions on which Carebricks is advancing care. Across partner institutions, agents have been built and deployed to strengthen clinical outcomes, operational performance, access, and productivity. Beyond the work recognized in this category, agents in production today autonomously code inpatient documentation at scale, automate specialty drug prior authorizations, abstract clinical registries, optimize perioperative clearance to reduce cancellations, and identify patients with chronic disease for earlier intervention.
"Artificial intelligence is rapidly redefining the way organizations operate, innovate, and compete," said Newsweek Editor-in-Chief Jennifer H. Cunningham. "The companies recognized through the AI Impact Awards are demonstrating the transformative potential of AI through thoughtful implementation, measurable results, and forward-looking leadership."
For more information about the 2026 Newsweek AI Impact Award winners and methodology, visit Newsweek’s website.
About Bunkerhill Health
Bunkerhill Health is the platform partner behind the modern health system. Its Carebricks platform empowers the country's leading health systems to bring any AI agent they envision to life — agents that reason across institutional data, take real action, and grow more powerful as more come online across the enterprise. Bunkerhill works alongside clinical and operational leaders to enable the agents and workflows they envision for their own institutions, rather than offering predefined solutions. As capability compounds, the institution begins to operate with a shared layer of intelligence reaching every part of its operation and every patient who passes through it.
About the Newsweek AI Impact Awards
The Newsweek AI Impact Awards recognize organizations applying artificial intelligence to drive innovation, improve operations, solve complex challenges, and create measurable business or societal impact. The program highlights companies demonstrating practical, responsible, and forward-looking uses of AI across industries.
About Newsweek
Newsweek is the global digital news organization built around the iconic 93-year-old American magazine. Newsweek reaches 100 million people monthly with its thought-provoking news, opinions, images, graphics, and video delivered across a dozen print and digital platforms. Headquartered in New York City, Newsweek also publishes international editions in EMEA and Asia.